Alexandre Betourne

Contact Alexandre

Alexandre Betourne

Executive Director

Critical Path Institute (C-Path)

Alexandre Betourne, Ph.D., Pharm.D., is Executive Director for the Rare Disease Cures Accelerator-Data and Analytics Platform initiative and previously served as its Scientific Director. Dr. Bétourné works with the RDCA-DAP team to expand its reach into new diseases areas accessing new data and enhancing C-Path’s relationships within the rare disease community. He holds both a PhD and a PharmD from the University of Toulouse in France, has three patents, and has written multiple papers that intersect with several different rare disease areas. Before joining C-Path, he led a team of senior U.S. scientists, CMC and regulatory consultants at a small company developing therapies for amyotrophic lateral sclerosis (ALS).

Talks About
#cellbiology #molecularbiology #innovator

Preferred Locations
#UnitedStates

Speaking Engagements

World Orphan Drug Congress USA 2023

Paid

Join us at the Gaylord National Resort & Convention Center in Washington, D.C. from May 23-25, 2023 for the world's most important orphan drug and rare disease event. With over 1,200 attendees, 100+ sponsors and exhibitors, 250+ speakers, and 13 themes of content, the World Orphan Drug Congress is the premier forum for breaking down silos and foste

23-25 May 2023

Healthcare

2023 RARE Advocacy Summit

Paid

Join us at the 2023 RARE Advocacy Summit, hosted by Global Genes, where the rare disease community comes together for an extraordinary gathering in San Diego, California. With attendees including rare disease patients, caregivers, advocates, healthcare professionals, researchers, partners, and allies, this summit stands as one of the world's larges

19-21 September 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER